Johnson & Johnson talc settlement reduces litigation overhang
A proposed $5.5 billion agreement to settle remaining talc-related ovarian cancer lawsuits aims to clear a major long-standing legal liability for Johnson & Johnson.
Sign in to read the full idea
The argument, what validates it, the risks discussed and hearing it from the source are for signed-in members. Free accounts read 3 ideas in full a day. No card required.